Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.99 HKD
−211.81 M HKD
229.81 M HKD
76.40 M
About SUZHOU BASECARE MEDICAL CORP LTD
Sector
Industry
CEO
Bo Liang
Website
Headquarters
Suzhou
Founded
2010
ISIN
CNE100004BC1
FIGI
BBG00YYTCJ18
Suzhou Basecare Medical Corp. Ltd. is an investment holding company, which engages in the provision of genetic testing solution for assisted reproduction. The firm is also involved in the sale of genetic testing devices and instruments. The company was founded by Bo Liang on December 14, 2010, and is headquartered in Suzhou, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2170 is 3.41 HKD — it has increased by 6.23% in the past 24 hours. Watch SUZHOU BASECARE MEDICAL CORP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SUZHOU BASECARE MEDICAL CORP LTD stocks are traded under the ticker 2170.
2170 stock has risen by 15.59% compared to the previous week, the month change is a 33.20% rise, over the last year SUZHOU BASECARE MEDICAL CORP LTD has showed a 26.30% increase.
2170 reached its all-time high on Feb 22, 2021 with the price of 34.85 HKD, and its all-time low was 1.29 HKD and was reached on Sep 20, 2024. View more price dynamics on 2170 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2170 stock is 8.23% volatile and has beta coefficient of 1.58. Track SUZHOU BASECARE MEDICAL CORP LTD stock price on the chart and check out the list of the most volatile stocks — is SUZHOU BASECARE MEDICAL CORP LTD there?
Today SUZHOU BASECARE MEDICAL CORP LTD has the market capitalization of 930.13 M, it has increased by 7.00% over the last week.
Yes, you can track SUZHOU BASECARE MEDICAL CORP LTD financials in yearly and quarterly reports right on TradingView.
SUZHOU BASECARE MEDICAL CORP LTD is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
2170 net income for the last half-year is −129.94 M HKD, while the previous report showed −140.79 M HKD of net income which accounts for 7.70% change. Track more SUZHOU BASECARE MEDICAL CORP LTD financial stats to get the full picture.
No, 2170 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 586.00 employees. See our rating of the largest employees — is SUZHOU BASECARE MEDICAL CORP LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUZHOU BASECARE MEDICAL CORP LTD EBITDA is −276.04 M HKD, and current EBITDA margin is −109.60%. See more stats in SUZHOU BASECARE MEDICAL CORP LTD financial statements.
Like other stocks, 2170 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUZHOU BASECARE MEDICAL CORP LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUZHOU BASECARE MEDICAL CORP LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUZHOU BASECARE MEDICAL CORP LTD stock shows the buy signal. See more of SUZHOU BASECARE MEDICAL CORP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.